Literature DB >> 15994997

Pulmonary arterial hypertension: diagnosis with fast perfusion MR imaging and high-spatial-resolution MR angiography--preliminary experience.

Konstantin Nikolaou1, Stefan O Schoenberg, Ulrike Attenberger, Juergen Scheidler, Olaf Dietrich, Bernd Kuehn, Frank Rosa, Armin Huber, Hanno Leuchte, Rainer Baumgartner, Juergen Behr, Maximilian F Reiser.   

Abstract

PURPOSE: To determine prospectively the accuracy of a magnetic resonance (MR) perfusion imaging and MR angiography protocol for differentiation of chronic thromboembolic pulmonary arterial hypertension (CTEPH) and primary pulmonary hypertension (PPH) by using parallel acquisition techniques.
MATERIALS AND METHODS: The study was approved by the institution's internal review board, and all patients gave written consent prior to participation. A total of 29 patients (16 women; mean age, 54 years +/- 17 [+/- standard deviation]; 13 men; mean age, 57 years +/- 15) with known pulmonary hypertension were examined with a 1.5-T MR imager. MR perfusion imaging (temporal resolution, 1.1 seconds per phase) and MR angiography (matrix, 512; voxel size, 1.0 x 0.7 x 1.6 mm) were performed with parallel acquisition techniques. Dynamic perfusion images and reformatted three-dimensional MR angiograms were analyzed for occlusive and nonocclusive changes of the pulmonary arteries, including perfusion defects, caliber irregularities, and intravascular thrombi. MR perfusion imaging results were compared with those of radionuclide perfusion scintigraphy, and MR angiography results were compared with those of digital subtraction angiography (DSA) and/or contrast material-enhanced multi-detector row computed tomography (CT). Sensitivity, specificity, and diagnostic accuracy of MR perfusion imaging and MR angiography were calculated. Receiver operator characteristic analyses were performed to compare the diagnostic value of MR angiography, MR perfusion imaging, and both modalities combined. For MR angiography and MR perfusion imaging, kappa values were used to assess interobserver agreement.
RESULTS: A correct diagnosis was made in 26 (90%) of 29 patients by using this comprehensive MR imaging protocol. Results of MR perfusion imaging demonstrated 79% agreement (ie, identical diagnosis on a per-patient basis) with those of perfusion scintigraphy, and results of MR angiography demonstrated 86% agreement with those of DSA and/or CT angiography. Interobserver agreement was good for both MR perfusion imaging and MR angiography (kappa = 0.63 and 0.70, respectively).
CONCLUSION: The combination of fast MR perfusion imaging and high-spatial-resolution MR angiography with parallel acquisition techniques enables the differentiation of PPH from CTEPH with high accuracy.

Entities:  

Mesh:

Year:  2005        PMID: 15994997     DOI: 10.1148/radiol.2361040502

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  21 in total

Review 1.  Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.

Authors:  Marjorie Barrier; Jolyane Meloche; Maria Helena Jacob; Audrey Courboulin; Steeve Provencher; Sébastien Bonnet
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

Review 2.  MR imaging of the pulmonary vasculature--an update.

Authors:  Mark R Pedersen; Mark T Fisher; Edwin J R van Beek
Journal:  Eur Radiol       Date:  2006-01-04       Impact factor: 5.315

Review 3.  [MRI of pulmonary embolism].

Authors:  C Fink; S Thieme; S Ley; D Clevert; M F Reiser; H-U Kauczor; S O Schoenberg
Journal:  Radiologe       Date:  2007-08       Impact factor: 0.635

Review 4.  The role of 1.5T cardiac MRI in the diagnosis, prognosis and management of pulmonary arterial hypertension.

Authors:  Gianluca Marrone; Giuseppe Mamone; Angelo Luca; Patrizio Vitulo; Alessandro Bertani; Michele Pilato; Bruno Gridelli
Journal:  Int J Cardiovasc Imaging       Date:  2010-03-25       Impact factor: 2.357

Review 5.  [MRI of pulmonary perfusion].

Authors:  C Fink; F Risse; W Semmler; S O Schoenberg; H-U Kauczor; M F Reiser
Journal:  Radiologe       Date:  2006-04       Impact factor: 0.635

Review 6.  [Magnetic resonance imaging of pulmonary perfusion. Technical requirements and diagnostic impact].

Authors:  U I Attenberger; M Ingrisch; K Büsing; M Reiser; S O Schoenberg; C Fink
Journal:  Radiologe       Date:  2009-08       Impact factor: 0.635

7.  Magnetic resonance imaging in pediatric pulmonary hypertension.

Authors:  Ayhan Pektas; Rana Olgunturk; Ayhan Cevik; Semiha Terlemez; Emre Kacar; Yusuf Ali Oner
Journal:  Tex Heart Inst J       Date:  2015-06-01

Review 8.  Pulmonary arterial hypertension: an imaging review comparing MR pulmonary angiography and perfusion with multidetector CT angiography.

Authors:  F P Junqueira; C M A O Lima; A C Coutinho; D B Parente; L K Bittencourt; L G P Bessa; R C Domingues; E Marchiori
Journal:  Br J Radiol       Date:  2012-08-29       Impact factor: 3.039

9.  Cavitating lung lesions in chronic thromboembolic pulmonary hypertension.

Authors:  Heather Harris; Richard Barraclough; Christine Davies; Iain Armstrong; David G Kiely; Edwin van Beek
Journal:  J Radiol Case Rep       Date:  2008-09-01

Review 10.  Contrast-enhanced CT- and MRI-based perfusion assessment for pulmonary diseases: basics and clinical applications.

Authors:  Yoshiharu Ohno; Hisanobu Koyama; Ho Yun Lee; Sachiko Miura; Takeshi Yoshikawa; Kazuro Sugimura
Journal:  Diagn Interv Radiol       Date:  2016 Sep-Oct       Impact factor: 2.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.